DiaKine Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2004-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.diakine.com
Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
- First Posted Date
- 2009-05-11
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- DiaKine Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00896077
- Locations
- 🇺🇸
Advanced Biomedical Research, Inc. (ABR), Hackensack, New Jersey, United States
© Copyright 2024. All Rights Reserved by MedPath